Piper Sandler analyst Korinne Wolfmeyer maintained a Buy rating on Colgate-Palmolive (CL – Research Report) today and set a price target of ...

A near-230 year sold company, Colgate-Palmolive continues to transform to meet the demands of the changing CPG markets.

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Colgate-Palmolive (NYSE:CL) and its peers.

Companies in the Consumer Goods sector have received a lot of coverage today as analysts weigh in on Walmart (WMT – Research Report) and ...

Colgate-Palmolive’s shares (currently trading at $87.88) have posted a disappointing 15.1% loss, well below the S&P 500’s 8.9 ...

Colgate chairman, president and CEO Noel Wallace described Prime100 as “a high-growth, profitable, fresh dog-food asset”.

Shares of Colgate-Palmolive rose 0.4% in after-hours trading on Tuesday as the company agreed to buy Care TopCo Pty Ltd, ...

Van ECK Associates Corp cut its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 96.0% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,466 shares of ...

As part of its growth strategy, which includes investing in faster-growing product segments adjacent to its core categories, Colgate-Palmolive Company ...

Reliance Securities Head of Research Vikas Jain and Prabhudas Lilladher Technical Research Vice President Vaishali Parekh ...

Colgate-Palmolive (India) Ltd is sharply focusing on growing consumption and driving premiumisation in the oral care segment.